WisdomTree BioRevolution UCITS ETF
WRNA.F
Frankfurt Stock Exchange- -
EUR
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- WisdomTree Issuer ICAV serves as an umbrella Irish collective asset-management vehicle that issues multiple UCITS-compliant exchange-traded funds, including the WisdomTree BioRevolution UCITS ETF USD Acc (tickers: WDNA, WBIO, WRNA.F), which tracks the WisdomTree BioRevolution ESG Screened Index. The ETF provides physical, fully replicated exposure to publicly listed companies significantly transformed by advancements in genetics and biotechnology, including human health, agriculture and food, materials and chemicals, energy, and biological machines and interfaces; it emphasizes firms with strong growth characteristics meeting WisdomTree's ESG criteria, such as exclusions for controversial weapons, tobacco, thermal coal, and unconventional oil and gas. The ICAV offers accumulating share classes in USD base currency with a total expense ratio of 0.45%, targeting institutional and retail investors seeking thematic equity investments in the biorevolution sector; key holdings include Intellia Therapeutics, uniQure, CRISPR Therapeutics, Ginkgo Bioworks, and Stoke Therapeutics. Founded on 20 September 2011 as a public limited company and converted to an ICAV on 6 May 2020, WisdomTree Issuer ICAV is domiciled in Ireland with its registered office at 3 Dublin Landings, North Wall Quay, Dublin 1. The vehicle operates globally through listings on exchanges such as the London Stock Exchange, Börse Xetra, and Deutsche Börse, serving investors across Europe and eligible for ISA, SIPP, and UCITS structures. Service providers include The Bank of New York Mellon as custodian, BNY Mellon Fund Services as administrator, Irish Life Investment Managers as fund manager, and Deloitte Ireland LLP as auditor. In recent developments, the WisdomTree BioRevolution UCITS ETF launched on 6 December 2021, expanding WisdomTree's thematic UCITS range amid growing interest in biotechnology megatrends. Effective around 23 June 2025, the ICAV transitioned its administrator and depositary from State Street Fund Services to BNY Mellon entities, enhancing operational efficiency. As of mid-2025, the ICAV maintains 33 active sub-funds, reflecting ongoing portfolio expansions and compliance updates including SFDR Article 8 categorization and index name adjustments ahead of EU guidelines effective 21 May 2025.